The LUDA partner digital pharmacy network has identified new supply issues with different medicines used to treat hepatitis.
As World Hepatitis Day was celebrated on Friday, the pharmacy network condemned the supply of drugs with the most complications, such as entecavir, used to treat chronic hepatitis B infection in adults and children, for hospital use. 2-year-old with liver damage, and “lamivudine” in the treatment of hepatitis B-infected patients with liver damage and dysfunction.
Viral hepatitis affects more than 300 million people worldwide. According to the World Health Organization (WHO), in addition to the clinical manifestations of the disease itself, viral hepatitis can also cause or exacerbate a series of problems for patients. First, it is related to overweight and related to diabetes.
In this sense, there is a problem with the availability of drugs used to treat these diseases, which are dispensed from pharmacies rather than hospitals.
medical prescription
For example, hepatitis C virus infection may lead to the development of diabetes. In such cases, doctors may prescribe medications such as “ozempic” or “saxenda,” which also have supply issues.
However, the Digital Pharmacy Network reminds that although some drugs may have substitutes, if the doctor has prescribed a specific prescription, the pharmacist has no right to replace the patient’s drug with another equivalent drug.
Therefore, “if the pharmacy is unable to fill the prescription due to supply problems, the patient must go back to the doctor, inform him of the situation and ask him to change the prescription. There is no doubt that this is a cumbersome and time-consuming process that directly affects seriously ill patients”, they added.